Once we achieve herd immunity, people who are not vaccinated benefit indirectly from the immunity of those around them. But it’s not easy to say exactly when we’ll reach this threshold for COVID-19.
Articles on COVID vaccines Australia
Displaying 41 - 60 of 63 articles
The federal government has announced COVID-19 vaccination will now become mandatory for aged-care workers. This comes amid a slow and troubled rollout in the sector.
Just like your memory, which improves by repeated viewing or listening with a break in between, our immune memory improves with repeated exposure.
By the time Australia is ready to deliver Novavax, we may well have completed most of the vaccine rollout with AstraZeneca, Pfizer and Moderna. That doesn’t mean Novavax won’t play an important role.
The rules around allocation, and the enforcement of those rules, can’t rest with each individual. Responsibility lies with those in charge of delivering vaccines.
Our attitudes and behaviours are shaped by what others in society do. So there’s a real danger that vaccine hesitancy, when reported widely in the media, could catch on to more people.
The federal government is due to launch a new advertising campaign for COVID-19 vaccines in July. This is a chance to offer something more engaging than what we’ve seen to date.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
The infection of a Victorian aged-worker who had received their first COVID vaccine dose isn’t completely surprising. We need two doses for optimal protection.
If new incentives don’t work, mandatory policies may be the only way forward in ensuring high COVID vaccine coverage of staff.
The COVID-19 variant responsible for Victoria’s latest outbreak is one of three Indian variant sub-types, which spreads more easily than the original strain. Here’s what we know so far.
In the end, the best protection is mass vaccination and ensuring as many people as possible are fully vaccinated as quickly as possible.
Many over 50s seem to be asking this question. But there are a number of reasons it’s important to go ahead and get the AstraZeneca vaccine now.
The United States and Canada have approved the Pfizer vaccine for adolescents aged 12–15. The evidence so far tells us it works well and is safe for this age group.
The TGA has reported a handful of cases of the autoimmune disorder Guillain-Barré syndrome following the AstraZeneca vaccine.
With a state election on Saturday, polls are showing different trends. Meanwhile, vaccine wariness among Australians is growing.
During the height of the pandemic, people with disability felt they had been forgotten and were not a priority. In the vaccine rollout, the government is repeating its past mistakes.
This shift in focus away from AstraZeneca to the Pfizer vaccine has serious impacts on the timing of the rollout and public confidence in the AstraZeneca vaccine.
We need to stop relying on small GP clinics and urgently move towards using mass vaccination hubs like stadiums, schools and parks.
Two residents in a Brisbane aged-care home were given a higher dose of the Pfizer vaccine than recommended. Here’s what might have happened – and how we can reduce the risk it will happen again.
Top contributors
-
Professor, The Children's Hospital at Westmead Clinical School and Sydney Infectious Diseases Institute, University of Sydney
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Professor, Infectious Diseases and Microbiology, The University of Queensland
-
Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Professor, School of Population Health, UNSW
-
Professor, School of Public Health, University of Sydney
-
Research Fellow, Vaccine Uptake Group, Murdoch Children's Research Institute
-
Vice Chancellors Senior Research Fellow in Immunology, RMIT University
-
Professor, School of Social Sciences, The University of Western Australia
-
Distinguished Professor, Professor of Immunology, RMIT University
-
Professor of Biostatistics and Epidemiology, Adelaide University
-
Laboratory Head, The Peter Doherty Institute for Infection and Immunity
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Election Analyst (Psephologist) at The Conversation; and Honorary Associate, School of Mathematics and Statistics, The University of Melbourne
-
Senior Lecturer; MD, Victoria University